{"related:PYmsJ_RA4f0J:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5":[{"title":"Soft regulations in pharmaceutical policy making","url":"https://link.springer.com/article/10.1007/BF03256147","authors":["B Wettermark","B Wettermark B Godman","B Wettermark B Godman B Jacobsson…"],"year":2009,"numCitations":99,"pdf":"https://www.researchgate.net/profile/Bjorn_Wettermark/publication/26865818_Soft_Regulations_in_Pharmaceutical_Policy_Making_An_Overview_of_Current_Approaches_and_their_Consequences/links/02e7e520d2e2e58ad9000000/Soft-Regulations-in-Pharmaceutical-Policy-Making-An-Overview-of-Current-Approaches-and-their-Consequences.pdf","citationUrl":"http://scholar.google.com/scholar?cites=18293974578737482045&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:PYmsJ_RA4f0J:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=18293974578737482045&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"Springer","p":1,"exp":1596876810135},{"title":"Enhancing the rational use of new medicines across European health care systems","url":"https://link.springer.com/article/10.1007/s00228-008-0537-z","authors":["S Garattini","S Garattini B Godman","S Garattini B Godman A Haycox","S Garattini B Godman A Haycox B Wettermark…"],"year":2008,"numCitations":83,"pdf":"https://link.springer.com/article/10.1007/s00228-008-0537-z","citationUrl":"http://scholar.google.com/scholar?cites=13480574036948705827&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:I2Ku2KmeFLsJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=13480574036948705827&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"Springer"},{"title":"Policies to enhance the efficiency of prescribing in the Spanish Catalan Region: impact and future direction","url":"https://www.tandfonline.com/doi/abs/10.1586/erp.09.58","authors":["A Coma","A Coma C Zara","A Coma C Zara B Godman","A Coma C Zara B Godman A Agustí…"],"year":2009,"numCitations":59,"pdf":"http://www.academia.edu/download/44723908/Policies_to_enhance_the_efficiency_of_pr20160414-7049-13tvty8.pdf","citationUrl":"http://scholar.google.com/scholar?cites=400146355432723290&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:WhO8ff2ajQUJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=400146355432723290&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"Taylor & Francis"},{"title":"Policies to enhance prescribing efficiency in Europe: findings and future implications","url":"https://www.frontiersin.org/articles/10.3389/fphar.2010.00141","authors":["B Godman","B Godman W Shrank","B Godman W Shrank M Andersen","B Godman W Shrank M Andersen C Berg…"],"year":2011,"numCitations":125,"pdf":"https://www.frontiersin.org/articles/10.3389/fphar.2010.00141","citationUrl":"http://scholar.google.com/scholar?cites=9011910708921240118&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:NgrK6Aq9EH0J:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=9011910708921240118&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"frontiersin.org"},{"title":"Impact of recent reforms in Austria on utilization and expenditure of PPIs and lipid-lowering drugs: implications for the future","url":"https://www.tandfonline.com/doi/abs/10.1586/erp.09.43","authors":["B Godman","B Godman T Burkhardt","B Godman T Burkhardt A Bucsics…"],"year":2009,"numCitations":60,"pdf":"https://www.researchgate.net/profile/Bjorn_Wettermark/publication/26883391_Impact_of_recent_reforms_in_Austria_on_utilization_and_expenditure_of_PPIs_and_lipid-lowering_drugs_Implications_for_the_future/links/551064d70cf2a8dd79bc8be5/Impact-of-recent-reforms-in-Austria-on-utilization-and-expenditure-of-PPIs-and-lipid-lowering-drugs-Implications-for-the-future.pdf","citationUrl":"http://scholar.google.com/scholar?cites=13845080932298635994&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:2rox6MCbI8AJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=13845080932298635994&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"Taylor & Francis"},{"title":"Influence of demand-side measures to enhance renin–angiotensin prescribing efficiency in Europe: implications for the future","url":"https://www.tandfonline.com/doi/abs/10.1586/erp.11.42","authors":["L Vončina","L Vončina T Strizrep","L Vončina T Strizrep B Godman…"],"year":2011,"numCitations":81,"pdf":"https://www.researchgate.net/profile/Iain_Bishop/publication/51561264_Influence_of_demand-side_measures_to_enhance_renin-angiotensin_prescribing_efficiency_in_Europe_Implications_for_the_future/links/54ddde050cf2814662eb9cb8.pdf","citationUrl":"http://scholar.google.com/scholar?cites=3093947839925153392&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:cG5TACvp7yoJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=3093947839925153392&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"Taylor & Francis"},{"title":"Initial effects of a reimbursement restriction to improve the cost-effectiveness of antihypertensive treatment","url":"https://www.sciencedirect.com/science/article/pii/S0168851009002577","authors":["B Wettermark","B Wettermark B Godman","B Wettermark B Godman M Neovius","B Wettermark B Godman M Neovius N Hedberg…"],"year":2010,"numCitations":75,"pdf":"http://www.academia.edu/download/44723916/Initial_effects_of_a_reimbursement_restr20160414-14314-nahftt.pdf","citationUrl":"http://scholar.google.com/scholar?cites=11414139201070053944&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:ODqk8CArZ54J:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=11414139201070053944&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"Elsevier"},{"title":"Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance","url":"https://www.tandfonline.com/doi/abs/10.1586/14737167.9.1.65","authors":["B Godman","B Godman B Wettermark","B Godman B Wettermark M Hoffmann…"],"year":2009,"numCitations":152,"pdf":"https://www.researchgate.net/profile/Bjorn_Wettermark/publication/24282162_Multifaceted_national_and_regional_drug_reforms_and_initiatives_in_ambulatory_care_in_Sweden_Global_relevance/links/56018f8b08aecb0ce8817072.pdf","citationUrl":"http://scholar.google.com/scholar?cites=16482548160225611882&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:ahCEMznGveQJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=16482548160225611882&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"Taylor & Francis"},{"title":"Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications","url":"https://www.tandfonline.com/doi/abs/10.1586/erp.10.72","authors":["B Godman","B Godman W Shrank","B Godman W Shrank M Andersen","B Godman W Shrank M Andersen C Berg…"],"year":2010,"numCitations":166,"pdf":"http://www.academia.edu/download/51475950/Comparing_policies_to_enhance_prescribin20170123-25558-8t52q9.pdf","citationUrl":"http://scholar.google.com/scholar?cites=14266846914305676945&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:kVYR-K0F_sUJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=14266846914305676945&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"Taylor & Francis"},{"title":"Financial incentives linked to self-assessment of prescribing patterns: a new approach for quality improvement of drug prescribing in primary care","url":"https://www.researchgate.net/profile/Bjorn_Wettermark/publication/26685859_Financial_incentives_linked_to_self-assessment_of_prescribing_patterns_A_new_approach_for_quality_improvement_of_drug_prescribing_in_primary_care/links/551065bf0cf2ba84483d8ce6.pdf","authors":["B Wettermark","B Wettermark Å Pehrsson…"],"year":2009,"numCitations":59,"pdf":"https://www.researchgate.net/profile/Bjorn_Wettermark/publication/26685859_Financial_incentives_linked_to_self-assessment_of_prescribing_patterns_A_new_approach_for_quality_improvement_of_drug_prescribing_in_primary_care/links/551065bf0cf2ba84483d8ce6.pdf","citationUrl":"http://scholar.google.com/scholar?cites=3546692904797284485&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:hSjX3WdiODEJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=3546692904797284485&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"researchgate.net"}]}